Immune modulation and increased neurotrophic factor production in multiple sclerosis patients treated with testosterone

Journal of Neuroinflammation

Volumn 5, Issue , 2008, Pages

  Gold, Stefan M ^a,b   Chalifoux, Sara ^a   Giesser, Barbara S ^a   Voskuhl, Rhonda R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CD4 ANTIGEN; CILIARY NEUROTROPHIC FACTOR; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 17; INTERLEUKIN 2; LACTATE DEHYDROGENASE; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; PLATELET DERIVED GROWTH FACTOR BB; TESTOSTERONE; TETANUS TOXOID; TRANSFORMING GROWTH FACTOR BETA1; CYTOKINE; GLUTAMIC ACID; IMMUNOLOGIC FACTOR; SIGNAL PEPTIDE;

ADULT; ANIMAL CELL; ARTICLE; BLOOD SAMPLING; BRAIN ATROPHY; CD4+ T LYMPHOCYTE; CELL ISOLATION; CLINICAL ARTICLE; CLINICAL OBSERVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; EXPANDED DISABILITY STATUS SCALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IN VIVO STUDY; LYMPHOCYTE SUBPOPULATION; MALE; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NEUROPROTECTION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN SYNTHESIS; SKIN TEST; TREATMENT DURATION; TREATMENT OUTCOME; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DRUG EFFECT; IMMUNE SYSTEM; IMMUNOLOGY; LYMPHOCYTE; METABOLISM; MIDDLE AGED; MOUSE; NERVE CELL;

ADULT; ANIMALS; CELLS, CULTURED; CROSS-OVER STUDIES; CYTOKINES; GLUTAMIC ACID; HUMANS; IMMUNE SYSTEM; IMMUNOLOGIC FACTORS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOCYTE SUBSETS; LYMPHOCYTES; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; MULTIPLE SCLEROSIS; NEURONS; TESTOSTERONE;

EID: 50149090664     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-5-32     Document Type: Article

References (41)

1. McFarland HF Martin R Multiple sclerosis: A complicated picture of autoimmunity Nat Immunol 2007, 8:913-9 10.1038/ni1507 17712344
2. Hemmer B Hartung HP Toward the development of rational therapies in multiple sclerosis: What is on the horizon? Ann Neurol 2007, 62:314-26 10.1002/ana.21289 17969020
3. Bebo BF Jr Zelinka-Vincent E Adamus G Amundson D Vandenbark AA Offner H Gonadal hormones influence the immune response to PLP 139-151 and the clinical course of relapsing experimental autoimmune encephalomyelitis J Neuroimmunol 1998, 84:122-130 10.1016/S0165-5728(97)00214-2 9628453
4. Smith ME Eller NL McFarland HF Racke MK Raine CS Age dependence of clinical and pathological manifestations of autoimmune demyelination. Implications for multiple sclerosis Am J Pathol 1999, 155:1147-1161 1867019 10514398
5. Ahmed SA Penhale WJ The influence of testosterone on the development of autoimmune thyroiditis in thymectomized and irradiated rats Clin Exp Immunol 1982, 48:367-374 1536459 7049452
6. Fitzpatrick F Lepault F Homo-Delarche F Bach JF Dardenne M Influence of castration, alone or combined with thymectomy, on the development of diabetes in the nonobese diabetic mouse Endocrinology 1991, 129:1382-1390 1874178
7. Fox HS Androgen treatment prevents diabetes in nonobese diabetic mice J Exp Med 1992, 175:1409-1412 2119211 1569406 10.1084/jem.175.5.1409
8. Harbuz MS Perveen-Gill Z Lightman SL Jessop DS A protective role for testosterone in adjuvant-induced arthritis Br J Rheumatol 1995, 34:1117-1122 10.1093/rheumatology/34.12.1117 8608351
9. Palaszynski KM Loo KK Ashouri JF Liu HB Voskuhl RR Androgens are protective in experimental autoimmune encephalomyelitis: Implications for multiple sclerosis J Neuroimmunol 2004, 146:144-52 10.1016/ j.jneuroim.2003.11.004 14698857
10. D'Agostino P Milano S Barbera C Di Bella G La Rosa M Ferlazzo V Farruggio R Miceli DM Miele M Castagnetta L Cillari E Sex hormones modulate inflammatory mediators produced by macrophages Ann N Y Acad Sci 1999, 876:426-429 10.1111/j.1749-6632.1999.tb07667.x 10415638
11. Li ZG Danis VA Brooks PM Effect of gonadal steroids on the production of IL-1 and IL-6 by blood mononuclear cells in vitro Clin Exp Rheumatol 1993, 11:157-162 8508557
12. Liva SM Voskuhl RR Testosterone acts directly on CD4+ T lymphocytes to increase IL-10 production J Immunol 2001, 167:2060-2067 11489988
13. Gold SM Voskuhl RR Testosterone replacement therapy for the treatment of neurological and neuropsychiatric disorders Curr Opin Investig Drugs 2006, 7:625-30 16869115
14. Bialek M Zaremba P Borowicz KK Czuczwar SJ Neuroprotective role of testosterone in the nervous system Pol J Pharmacol 2004, 56:509-518 15591638
15. Ogata T Nakamura Y Tsuji K Shibata T Kataoka K Steroid hormones protect spinal cord neurons from glutamate toxicity Neuroscience 1993, 55:445-449 10.1016/0306-4522(93)90513-F 8104320
16. Lustig RH Sex hormone modulation of neural development in vitro Horm Behav 1994, 28:383-395 10.1006/hbeh.1994.1035 7729807
17. Kerschensteiner M Gallmeier E Behrens L Leal VV Misgeld T Klinkert WE Kolbeck R Hoppe E Oropeza-Wekerle RL Bartke I Stadelmann C Lassmann H Wekerle H Hohlfeld R Activated human T cells, B cells and monocytes produce brain-derived neurotrophic factor (BDNF) in vitro and in brain lesions: A neuroprotective role of inflammation? J Exp Med 1999, 189:865-870 2192942 10049950 10.1084/jem.189.5.865
18. Hammarberg H Lidman O Lundberg C Eltayeb SY Gielen AW Muhallab S Svenningsson A Lindå H Meide van Der PH Cullheim S Olsson T Piehl F Neuroprotection by encephalomyelitis: Rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells J Neurosci 2000, 20:5283-5291 10884312
19. Hohlfeld R Neurotrophic cross-talk between the nervous and immune systems: Relevance for repair strategies in multiple sclerosis? J Neurol Sci 2008, 265:93-6 10.1016/j.jns.2007.03.012 17459415
20. Sicotte NL Giesser BS Tandon V Klutch R Steiner B Drain AE Shattuck DW Hull L Wang HJ Elashoff RM Swerdloff RS Voskuhl RR Testosterone treatment in multiple sclerosis: A pilot study Arch Neurol 2007, 64:683-688 10.1001/archneur.64.5.683 17502467
21. Sicotte NL Liva SM Klutch R Pfeiffer P Bouvier S Odesa S Wu TC Voskuhl RR Treatment of multiple sclerosis with the pregnancy hormone estriol Ann Neurol 2002, 52:421-8 10.1002/ana.10301 12325070
22. Soldan SS Alvarez Retuerto AI Sicotte NL Voskuhl RR Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol J Immunol 2003, 171:6267-74 14634144
23. Gonsette RE Oxidative stress and excitotoxicity: A therapeutic issue in multiple sclerosis? Mult Scler 2008, 14:22-34 10.1177/1352458507080111 17881394
24. Sospedra M Martin R Immunology of multiple sclerosis Annu Rev Immunol 2005, 23:683-747 10.1146/annurev.immunol.23.021704.115707 15771584
25. Morandi B Bramanti P Bonaccorsi I Montalto E Oliveri D Pezzino G Navarra M Ferlazzo G Role of natural killer cells in the pathogenesis and progression of multiple sclerosis Pharmacol Res 2008, 57:1-5 18182304
26. Bielekova B Richert N Howard T Blevins G Markovic-Plese S McCartin J Frank JA Würfel J Ohayon J Waldmann TA McFarland HF Martin R Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon beta Proc Natl Acad Sci USA 2004, 101:8705-8708 423259 15161974 10.1073/pnas.0402653101
27. Bielekova B Catalfamo M Reichert-Scrivner S Packer A Cerna M Waldmann TA McFarland H Henkart PA Martin R Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis Proc Natl Acad Sci USA 2006, 103:5941-6 1458677 16585503 10.1073/pnas.0601335103
28. Rubtsov YP Rudensky AY TGFβ signalling in control of T-cell-mediated self-reactivity Nat Rev Immunol 2007, 7:443-453 10.1038/ nri2095 17525753
29. Racke MK Dhib-Jalbut S Cannella B Albert PS Raine CS McFarlin DE Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1 J Immunol 1991, 146:3012-3017 1707929
30. Calabresi PA Fields NS Maloni HW Hanham A Carlino J Moore J Levin MC Dhib-Jalbut S Tranquill LR Austin H McFarland HF Racke MK Phase 1 trial of transforming growth factor beta 2 in chronic progressive MS Neurology 1998, 51:289-292 9674825
31. Brann DW Dhandapani K Wakade C Mahesh VB Khan MM Neurotrophic and neuroprotective actions of estrogen: Basic mechanisms and clinical implications Steroids 2007, 72:381-405 2048656 17379265 10.1016/ j.steroids.2007.02.003
32. Muhallab S Lundberg C Gielen AW Lidman O Svenningsson A Piehl F Olsson T Differential expression of neurotrophic factors and inflammatory cytokines by myelin basic protein-specific and other recruited T cells infiltrating the central nervous system during experimental autoimmune encephalomyelitis Scand J Immunol 2002, 55:264-273 10.1046/ j.0300-9475.2002.01038.x 11940233
33. Stadelmann C Kerschensteiner M Misgeld T Brück W Hohlfeld R Lassmann H BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells? Brain 2002, 125:75-85 10.1093/brain/awf015 11834594
34. Caggiula M Batocchi AP Frisullo G Angelucci F Patanella AK Sancricca C Nociti V Tonali PA Mirabella M Neurotrophic factors and clinical recovery in relapsing-remitting multiple sclerosis Scand J Immunol 2005, 62:176-82 10.1111/j.1365-3083.2005.01649.x 16101825
35. Weinstock-Guttman B Zivadinov R Tamaño-Blanco M Abdelrahman N Badgett D Durfee J Hussein S Feichter J Patrick K Benedict R Ramanathan M Immune cell BDNF secretion is associated with white matter volume in multiple sclerosis J Neuroimmunol 2007, 188:167-74 10.1016/ j.jneuroim.2007.06.003 17602759
36. Lykissas MG Batistatou AK Charalabopoulos KA Beris AE The role of neurotrophins in axonal growth, guidance, and regeneration Curr Neurovasc Res 2007, 4:143-51 10.2174/156720207780637216 17504212
37. Tseng HC Dichter MA Platelet-derived growth factor-BB pretreatment attenuates excitotoxic death in cultured hippocampal neurons Neurobiol Dis 2005, 19:77-83 10.1016/j.nbd.2004.11.007 15837563
38. Kawabe T Wen TC Matsuda S Ishihara K Otsuda H Sakanaka M Platelet-derived growth factor prevents ischemia-induced neuronal injuries in vivo Neurosci Res 1997, 29:335-43 10.1016/ S0168-0102(97)00105-3 9527625
39. Henrich-Noack P Prehn JH Krieglstein J Neuroprotective effects of TGF-beta 1 J Neural Transm Suppl 1994, 43:33-45 7884405
40. Thoenen H Sendtner M Neurotrophins: From enthusiastic expectations through sobering experiences to rational therapeutic approaches Nat Neurosci 2002, 5(Suppl):1046-50 10.1038/nn938 12403983
41. Esiri MM The interplay between inflammation and neurodegeneration in CNS disease J Neuroimmunol 2007, 184:4-16 10.1016/j.jneuroim.2006.11.013 17187866